Showing results (431-440 of 689) with videos related to

Sort By:
Pageof 69
Journal of the American College of Cardiology|September 14, 1999
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10BM J Tanasijevic, C P Cannon, E M Antman, et al.
Journal of the American College of Cardiology|October 16, 1999
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarctionC M Gibson, K A Ryan, S A Murphy, et al.
The American Journal of Cardiology|November 15, 2000
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigatorsJ A de Lemos, E M Antman, R P Giugliano, et al.
The American Journal of Cardiology|June 29, 2004
Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarctionC Michael Gibson, Brian Bigelow, David James, et al.
Cancer|June 1, 1997
Dihydro-5-azacytidine in malignant mesothelioma. A phase II trial demonstrating activity accompanied by cardiac toxicity. Cancer and Leukemia Group BN J Yogelzang, J E Herndon, C Cirrincione, et al.
Critical Care Medicine|December 4, 2008
A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response RegistryClaudio M Martin, Fran Priestap, Harold Fisher, et al.
The American Journal of Cardiology|January 31, 2007
Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial)Marc P Bonaca, Stephen D Wiviott, Marc S Sabatine, et al.
The New England Journal of Medicine|September 8, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppressionK S Antman, J D Griffin, A Elias, et al.
American Heart Journal|January 6, 2005
Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trialHoward A Cooper, Michael J Domanski, Yves Rosenberg, et al.
Clinical Cardiology|March 23, 2013
Relation between time of symptom onset of ST-segment elevation myocardial infarction and patient baseline characteristics: from the National Cardiovascular Data RegistryOwen Mogabgab, Stephen D Wiviott, Elliot M Antman, et al.
Pageof 69